HealthcareServices

Global Point-of-Care Glucose Testing Industry Trends and Market Forecast 2026–2030

March 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the point-of-care glucose testing market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Point-of-Care Glucose Testing Market show for the 2026–2030 period?

The market for point-of-care glucose testing has demonstrated significant growth over the past few years. It is forecast to expand from $5.14 billion in 2025 to $5.44 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.8%. This growth observed in prior periods can be attributed to the rising incidence of diabetes, increased engagement in self-monitoring practices, the widespread availability of cost-effective glucose meters, the broader provision of outpatient diabetes care, and an enhanced understanding of glycemic control.

The point-of-care glucose testing market is projected to experience substantial expansion in the coming years, with its size anticipated to reach $6.95 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.3%. This growth during the forecast period stems from factors such as the increasing uptake of connected glucose monitoring systems, greater integration with mobile health applications, a rising need for non-invasive monitoring solutions, the broadening of remote patient monitoring initiatives, and an intensifying emphasis on tailored diabetes management. Key trends expected over the forecast period encompass the wider adoption of Bluetooth-enabled glucose meters, the increasing utilization of continuous glucose monitoring devices, a rising preference for glucose testing performed at home, the expansion of digital platforms for diabetes management, and an amplified focus on patients monitoring themselves.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp

What Drivers Are Shaping The Development Of The Point-of-Care Glucose Testing Market?

The increasing occurrence of diabetes is anticipated to propel the expansion of the point-of-care glucose testing market moving forward. Diabetes is a chronic metabolic condition that elevates blood glucose levels, potentially leading over time to severe damage in the heart, blood vessels, eyes, kidneys, and nerves. Point-of-care glucose testing is a frequently employed technology for determining glucose levels in hospitalized patients, aiding in prompt treatment decisions in response to glycemia changes, and enhancing therapeutic outcomes and diabetes management. For instance, in June 2024, according to the National Health Service (NHS England), a UK-based publicly funded healthcare system, in 2023, the number of individuals identified by the NHS in England as having pre-diabetes rose to 3,615,330, indicating an 18% increase from 3,065,825 in 2022. Additionally, among those under 40, cases surged nearly 25%, growing from 173,166 in 2022 to 216,440 in 2023. Therefore, the growing prevalence of diabetes is driving the growth of the point-of-care glucose testing market.

What Segment Types Are Examined In The Point-of-Care Glucose Testing Market?

The point-of-care glucose testing market covered in this report is segmented –

1) By Product: Lancet And Lancing Devices, Strips, Meters

2) By Testing Site: Fingertips, Alternate Site Testing

3) By Applications: Type-1 Diabetes, Type-2 Diabetes

4) By End-User: Professional Diagnostic Centers, Hospitals And Clinics, Home Care Settings, Other End Users

Subsegments:

1) By Lancet And Lancing Devices: Single-Use Lancets, Multi-Use Lancets, Adjustable Lancing Devices

2) By Strips: Glucose Test Strips, Ketone Test Strips, Combo Strips (Glucose And Ketone)

3) By Meters: Blood Glucose Meters, Continuous Glucose Monitoring (CGM) Meters, Bluetooth-Enabled Meters

How Are Emerging Trends Affecting The Progression Of The Point-of-Care Glucose Testing Market?

Within the point-of-care glucose testing market, leading companies are concentrating on creating sophisticated technological solutions, notably wearable continuous glucose monitoring (CGM) systems incorporating predictive analytics. These innovations aim to bolster real-time glucose surveillance, optimize glycemic management, and alleviate the necessity for frequent manual testing. Such CGM systems operate via a compact sensor placed beneath the skin, which constantly records interstitial glucose readings and transmits this information to a mobile application, facilitating proactive health management through instant alerts and forecasts of glucose trends. An illustrative example is the launch of the Accu-Chek SmartGuide CGM system by Roche, a diagnostics company based in Switzerland, in July 2024, specifically developed for individuals with diabetes. This device delivers live glucose measurements every five minutes, incorporates AI-driven trend forecasting for up to two hours in advance, provides nocturnal warnings for low or high blood sugar, and links effortlessly to a mobile app for comprehensive data monitoring and remote health supervision, thereby significantly improving safety and user convenience when contrasted with conventional finger-prick glucose devices.

Who Are The Top-Performing Companies In The Point-of-Care Glucose Testing Market In Recent Years?

Major companies operating in the point-of-care glucose testing market are F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Siemens Healthineers, TaiDoc Technology Corporation, Nipro Corporation, Dexcom Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc., Medtronic plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

Which Region Currently Holds The Largest Share Of The Point-of-Care Glucose Testing Market?

North America was the largest region in the point-of-care glucose testing market in 2025. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Point-of-Care Glucose Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12207&type=smp

Browse Through More Reports Similar to the Global Point-of-Care Glucose Testing Market 2026, By The Business Research Company

Blood Glucose Monitoring Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-glucose-monitoring-systems-global-market-report

Blood Glucose Meters Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Continous Blood Glucose Monitoring Market Report 2026

https://www.thebusinessresearchcompany.com/report/continous-blood-glucose-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795